Can we prevent, reduce or reverse intestinal fibrosis in IBD?

Latella, G; Sferra, R; Speca, S; Vetuschi, A; Gaudio, E

Latella, G; Sferra, R; Speca, S; Vetuschi, A; Gaudio, E.

Affiliation

Latella G; Department of Life, Health and Environmental Sciences, Gastroenterology Unit, University of L'Aquila, L'Aquila, Italy. giolatel@tin.it

Eur Rev Med Pharmacol Sci ; 17(10): 1283-304, 2013 May.

Article in En | MEDLINE | ID: mdl-23740440

Subject(s)

Inflammatory Bowel Diseases/complications; Intestines/pathology; Extracellular Matrix/metabolism; Fibrosis/drug therapy; Fibrosis/prevention & control; Humans; PPAR gamma/metabolism; Signal Transduction; Transforming Growth Factor beta/physiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Intestines Type of study: Prognostic_studies Limits: Humans Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2013 Document type: Article Country of publication: Italy

Search on Google

Add to My VHL

XML

PubMed Links